Thoracic pathology
June 11–13, 2025
Stockholm, Swedish Society of Medicine
Registration for the 2025 course opens in January 2025!
The course consists of classroom lectures and quizzes, as well as workshops with selected cases directed by the instructors. Attendees will work with a digital microscope throughout the course and will be given full command of the slides.
The full course syllabus will be available soon.
Lectures and workshops will be held IN PERSON at the Swedish Society of Medicine. English is the official language of the course.
“I really like the format of this course (pre-recorded lectures combined with real time workshops with cases). To see all lectures at the beginning was very profitable and in this way I could discuss and learn easily during the workshop.”
The course is targeted to pathology trainees or early pathology specialists.
It consists of two parts:
Part I. Common tumoral lung and pleural diseases and molecular diagnosis;
Part II. Non-neoplastic lung diseases.
Each part consists of classroom lectures and quizzes, as well as workshops with selected cases directed by the instructors. Attendees will work with a digital microscope throughout the course and will be given full command of the slides.
Lectures and workshops will be held IN PERSON at the Swedish Society of Medicine. English is the official language of the course.
An interactive course in thoracic pathology combining real-time workshops with independent learning
“I liked everything, everything was useful and valuable. I can’t wait to follow the course next year.”
You will work with a digital microscope throughout the course, giving you the full command of the slides.
“The possibility to review the cases before the workshop was a big advantage. ”
Faculty
Prof. Anja C. Roden, M.D.
Dr. Anja C. Roden is Professor of Laboratory Medicine and Pathology and is a board certified Anatomic and Clinical Pathologist with special interest in thoracic pathology.
Dr. Roden received her medical training at the Humboldt University in Berlin and Technical University in Dresden, Germany. After training in general surgery and working in basic immunology science she completed her anatomic and clinical pathology residency, surgical pathology fellowship, and pulmonary Mayo Clinic scholarship at Mayo Clinic Rochester, US. Subsequently, she joined the staff of the Department of Laboratory Medicine and Pathology at Mayo Clinic Rochester, MN, USA. Dr. Roden also serves as the Medical Director of the Immunostains Laboratory, the Pulmonary Pathology Fellowship Director, and the head of the thoracic transplant section.
Dr. Roden focuses her research on mediastinal neoplasms, mesothelioma, biomarkers, and pulmonary transplant pathology. She published her work in over 190 peer-reviewed manuscripts, wrote more than 40 book chapters and co-edited 2 textbooks on mediastinal, pulmonary, and mesothelial neoplasms and non-neoplastic lung disease. Following her interests, she chairs the thymic carcinoma and mediastinal working groups of the International Thymic Malignancy Interest Group, is a member of the steering committee of the thymic domain of the International Association for the Study of Lung Cancer for the 10th TNM staging and is a member of an International Mesothelioma Panel and an International Virtual Thymoma Panel. She is the immediate Past-President of the International Thymic Malignancy Interest Group, chair of the thymic subcommittee of the rare tumor committee of the International Association for the Study of Lung Cancer, co-chair of the mediastinal working group of the European Society of Pathology, and the immediate past chair of the pathology community network of the International Society of Heart and Lung Transplantation.
Cristian Ortiz-Villalón, M.D. PhD PhD MBA
Dr. Ortiz-Villalón is a distinguished expert in pulmonary pathology with an extensive background in both clinical practice and research. He holds an MD from the University of Concepción/University of Valencia, a PhD from Kyoto University, Japan, and a PhD from the University of Valencia, Spain. His notable positions include Head of the Department of Pathology at Karolinska University Hospital-Danderyd, Sweden, and Senior Director of Global Medical Affairs Diagnostics at AstraZeneca. Dr. Ortiz-Villalón has also served as President of the Swedish Society of Pathology and is an Affiliated researcher at Karolinska Institute and guest professor at Nagasaki University. His significant contributions include founding Pathology Science OÜ, contributing implementing digital pathology at Karolinska University Hospital, and authoring guidelines for lung cancer, mesothelioma, and ILD.
“The interaction between instructors and students was very helpful to change the way you learn a certain subject. Besides, the instructors were very kind to correct you and show you the right interpretation of the biopsies”